Park, G.; Choi, B.; Kang, S.; Kim, B.; Chang, M.J.
Sodium–Glucose Cotransporter-2 Inhibitors Could Help Delay Renal Impairment in Patients with Type 2 Diabetes: A Real-World Clinical Setting. J. Clin. Med. 2022, 11, 5259.
https://doi.org/10.3390/jcm11185259
AMA Style
Park G, Choi B, Kang S, Kim B, Chang MJ.
Sodium–Glucose Cotransporter-2 Inhibitors Could Help Delay Renal Impairment in Patients with Type 2 Diabetes: A Real-World Clinical Setting. Journal of Clinical Medicine. 2022; 11(18):5259.
https://doi.org/10.3390/jcm11185259
Chicago/Turabian Style
Park, Gyunam, Byungha Choi, Soyoung Kang, Bomin Kim, and Min Jung Chang.
2022. "Sodium–Glucose Cotransporter-2 Inhibitors Could Help Delay Renal Impairment in Patients with Type 2 Diabetes: A Real-World Clinical Setting" Journal of Clinical Medicine 11, no. 18: 5259.
https://doi.org/10.3390/jcm11185259
APA Style
Park, G., Choi, B., Kang, S., Kim, B., & Chang, M. J.
(2022). Sodium–Glucose Cotransporter-2 Inhibitors Could Help Delay Renal Impairment in Patients with Type 2 Diabetes: A Real-World Clinical Setting. Journal of Clinical Medicine, 11(18), 5259.
https://doi.org/10.3390/jcm11185259